Literature DB >> 10981914

Taxanes as adjuvant for breast cancer.

A Goldhirsch, P Francis, M Castiglione-Gertsch, R D Gelber, A S Coates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10981914     DOI： 10.1016/S0140-6736(05)74177-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Docetaxel-induced nail changes--a neurogenic mechanism: a case report.

Authors:  Gunnar Wasner; Felix Hilpert; Jörn Schattschneider; Andreas Binder; Jacobus Pfisterer; Ralf Baron
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

2.  Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.

Authors:  M Colleoni; H J Litman; M Castiglione-Gertsch; W Sauerbrei; R D Gelber; M Bonetti; A S Coates; M Schumacher; G Bastert; C-M Rudenstam; C Schmoor; J Lindtner; J Collins; B Thürlimann; S B Holmberg; D Crivellari; C Beyerle; R L A Neumann; A Goldhirsch
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

3.  Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.

Authors:  V Lorusso; E Crucitta; N Silvestris; A Catino; L Caporusso; A Mazzei; M Guida; A Latorre; D Sambiasi; C D'Amico; F Schittulli; P Calabrese; M De Lena
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.